|
|
||||||||
1 Departments of Pediatrics and
Physiology, Tyrosine kinases (TKs) exert multiple regulatory roles in
neuronal activity and synaptic plasticity and could be involved in
modulation of cardiovascular and respiratory control mechanisms within
the dorsocaudal brain stem. To study this issue, the
cardioventilatory responses to 1-µl microinjection within the
dorsocaudal brain stem of either vehicle (Veh), the inactive TK
inhibitor analog tyrphostin A1 (A1; 1 mM), or the active TK inhibitors
genistein (Gen; 10 mM) and tyrphostin A25 (A25; 1 mM) were assessed by
whole body plethysmography in unrestrained Sprague-Dawley adult rats. No changes in minute ventilation, heart rate, or mean arterial pressure
occurred with Veh, A1, Gen, or A25 during room air breathing (P not significant). However, Gen and
A25 attenuated the peak hypoxic ventilatory responses (HVR) to 10%
O2
(P < 0.006 vs. Veh), whereas A1 did
not modify HVR (P not significant).
HVR reductions by Gen and A25 were primarily due to diminished
respiratory frequency enhancements (P < 0.002). No changes in heart rate or mean arterial pressure
responses occurred during hypoxia with TK inhibition. In addition,
increases in tyrosine phosphorylation of the NR2A/B subunits, but not
of the NR2C subunit, of the
N-methyl-D-aspartate receptor occurred at 5, 30, and 60 min of hypoxia in the dorsocaudal brain stem and returned to baseline values at 120 min. We conclude that
hypoxia induces tyrosine phosphorylation of the
N-methyl-D-aspartate glutamate receptor, and TK inhibition within the dorsocaudal brain stem
attenuates components of HVR in conscious rats.
respiratory regulation; second messengers; dorsal brain stem; ventilation; tyrosine kinases; signal transduction pathways
MULTIPLE STUDIES FROM VARIOUS laboratories have shown
that
N-methyl-D-aspartate
(NMDA) glutamate receptors within the dorsocaudal brain stem mediate
important aspects of respiratory pattern generation and cardiovascular
regulation and also underlie critical components of the hypoxic
ventilatory response (HVR; Refs. 2, 19, 22, 28). NMDA glutamate
receptors are structurally heterodimers, which are composed from NR1
and NR2 subunits (9). In hippocampal neurons, activation of the NMDA
receptor involves tyrosine phosphorylation of the NR2 subunit as an
early event (16). In addition, application of tyrosine kinase (TK)
inhibitors will markedly attenuate NMDA receptor channel currents (7,
35, 36), whereas administration of tyrosine phosphatase (TP) inhibitors
will result in enhanced neuronal discharge (35, 36). Conversely, anoxia
and resultant neuronal depression in hippocampal slices elicit a
decrease in TK activity, particularly of the
src TK family, leading to tyrosine dephosphorylation of the NMDA NR2A/2B subunits (5). Therefore, TK-mediated pathways appear to mediate components of neuronal excitability within brain regions that do not subserve specific respiratory tasks.
In previous studies from our laboratory, we have shown that inhibition
of protein kinase C (PKC) activity within the dorsocaudal brain stem
resulted in significant attenuation of the HVR in conscious rats,
whereas administration of membrane-permeable PKC activators induced
marked ventilatory enhancements during normoxia (13, 14). However, the
contribution of PKC activity changes to the HVR does not fully account
for the overall increases in ventilatory output (12, 14). Thus it is
conceivable that multiple kinase systems are involved in HVR. Based on
the previously demonstrated modulation of NMDA receptor channel
activity by TK in the hippocampus and the more recent observation that
TK activity in vivo alters the baroreflex response in anesthetized rats
(23), we hypothesized that administration of TK inhibitors to the
dorsocaudal brain stem of adult rats would be associated with HVR
attenuation. To examine this issue, normoxic and hypoxic
cardioventilatory responses were assessed in chronically instrumented,
freely behaving adult rats before and after administration of the
selective TK inhibitors genistein (Gen) and tyrphostin A25 (A25).
Adult male Sprague-Dawley rats (280-320 g) were purchased from a
commercial breeder (Charles River). The experimental protocols were
approved by the Institutional Animal Use and Care Committee. Animals
were provided with water and rat chow ad libitum, kept on a 12:12-h
light-dark cycle, and at 22 ± 1°C ambient temperature for at
least 1 wk of habituation before surgery and during the postoperative
period. For habituation purposes, the animals spent at least 1-2 h
each day in a whole body plethysmographic chamber.
Surgical animal preparation.
Anesthesia was induced by pentobarbital sodium (50 mg/kg ip, Nembutal),
and core temperature was maintained at 37.5°C via a
servo-controlled Harvard rectal temperature probe connected to a
warming blanket. A 1-cm incision of the left inguinal skin was
performed, and an indwelling polyethylene catheter (PE-50) was inserted
into the left femoral artery and advanced to the abdominal aorta for
sampling of blood and measurement of cardiovascular parameters. The
catheter was secured in the groin and exteriorized in the dorsal aspect
of the neck. The arterial line was flushed with heparinized saline
(1,000 U/ml), sealed with heat, and stored in a plastic cap sutured to
the skin between the shoulder blades. The animals were placed in a
stereotaxic apparatus (Kopf Instruments), and a small diameter hole was
drilled into the occipital skull. A small cannula (22G; Plastics One,
Roanoke, VA) was surgically implanted at or in close proximity to the
nucleus of the solitary tract according to standard stereotaxic
coordinates (
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
13.85 mm bregma, 0.2 mm off midline, 8.0 mm depth;
Ref. 27). After surgery, animals were allowed to recover for at least
48 h, as demonstrated by the return to normal feeding and sleep-waking patterns.
Ventilatory and cardiovascular measurements.
Cardiorespiratory measures were continuously measured in the freely
behaving, unrestrained animal in a calibrated 3-liter barometric
chamber (Buxco Electronics, Troy, NY) by using methods described by
Barlett and Tenney (3) and Pappenheimer (29). To minimize the effect of
signal drift due to external temperature and pressure changes, a
reference chamber of equal size, in which the temperature was measured
by a T-type thermocouple, was used. In addition, as previously
recommended by Epstein and colleagues (10), a correction factor was
incorporated into the software routine to account for inspiratory and
expiratory barometric asymmetries. Chamber temperature was maintained
slightly below the thermoneutral range (24-28°C). A
calibration volume of 0.5 ml of air was repeatedly introduced into the
chamber before and on completion of the recordings to monitor chamber
calibration. At least 60 min before the start of each protocol, animals
were allowed to acclimate to the chamber, in which humidified air (90%
relative humidity) was passed through at a rate of 5 l/min by using a
precision flow pump-reservoir system. Pressure changes in the chamber
due to the inspiratory and expiratory changes were measured by using a
high-gain differential pressure transducer (model MP45-1,
Validyne; Ref. 8). Analog signals were continuously digitized and
analyzed on-line by a microcomputer software program (Buxco
Electronics). A rejection algorithm was included in the
breath-by-breath analysis routine and allowed for accurate rejection of
motion-induced artifacts, according to rejection parameters established
for minimum acceptable tidal volume
(VT), as well as minimum and
maximum inspiratory times, and the acceptable ratios of inspiratory and
expiratory VT values.
VT, respiratory frequency (f),
and minute ventilation (
E) were
computed breath by breath throughout all baseline and experimental
periods and subsequently stored for off-line analysis.
Chemicals.
The TK inhibitors Gen (4',5,7-trihydroxyisoflavone) and A25
[
-cyano-(3,4,5-trihydroxy)cinnamonitrile] and the
inactive TK inhibitor analog tyrphostin A1 [A1;
(4-methoxybenzylidene)malononitrile;
-cyano-(4-methoxy)cinnamonitrile] were purchased from
Calbiochem (La Jolla, CA).
Experimental protocol. In preliminary experiments, the optimal dosages for Gen and A25 were determined by dissolving these drugs in 0.1 ml DMSO and 1.9 ml artificial CSF and microinjecting them (1 µl) at increasing concentrations ranging from 0.0-10 mM into the dorsocaudal brain stem of one to two rats per dose. The lowest dose that attained maximal inhibitory cardiorespiratory effects during hypoxia was then chosen as the optimal dosage for microinjection during the experiments.
At the onset of each experiment, a 1-µl microinjection of L-glutamate (100 nmol in 1 µl) was administered to each rat such that proper positioning of the guide cannula within the NTS could be tentatively verified (15). The temporal sequence of experiments consisted then of an initial microinjection of 1 µl of vehicle (Veh) after which cardiorespiratory measurements were recorded in normoxia. At this point, hypoxic cardioventilatory responses to 10% O2 were assessed for 20 min. Animals were then allowed to recover for 2 h, after which new baseline values were obtained for each animal, followed by microinjection of 1 µl containing Gen (10 mM), A25 (1 mM), or A1 (1 mM), followed by 30 min of normoxia and then 20 min in 10% O2. It should be stressed that both ventilatory and cardiovascular parameters were continuously recorded throughout the experiments.Measurement of blood-gas values. Arterial blood samples were obtained from the implanted arterial catheter. After withdrawal of 75-100 µl of blood in the dead space of the catheter, another 150 µl were sampled for immediate analysis of PO2, PCO2, and pH with a blood-gas analyzer (model 178, Ciba Corning). Measurements were always performed in room air and during the last minute of each hypoxic challenge.
Tissue lysate preparation, immunoprecipitation, and immunoblotting
procedures.
Animals were killed by decapitation at time
0 and minutes 5, 30, 60, and 120 of hypoxic
exposure to 10% O2-balance 90%
N2. Heads were quickly frozen in
42°C isopentane for 5 min and stored at
70°C. For
dissection, brains were warmed to
5°C. The obex was visually
identified, and a coronal section 1 mm caudal to 1 mm rostral to the
obex was performed. The dorsal regions of the caudal brain stem were
identified, carefully removed by using a 17-gauge thin-walled
hypodermic needle for punch-sampling, and stored at
70°C.
Approximately 10 mg of tissue were obtained from each rat. Tissues
corresponding to the dorsal regions of the caudal brain stem from six
animals were pooled and homogenized at 4°C in lysis buffer (1 M
Tris, pH 7.5, 250 mM EGTA, 250 mM
MnCl2, 10 mM sodium orthovanadate,
200 mM phenylmethylsulfonyl fluoride, 1 M
-glycerophosphate). Crude
synaptosomes were isolated by centrifuging the homogenates for 10 min
at 1,000 g and further centrifugation of supernatants at 15,000 g for 20 min. The resultant pellet was resuspended, washed three times in HEPES
(pH 7.2) containing 1 mM EDTA, and centrifuged at 15,000 g for 20 min. Protein content was
assayed by using a commercially available kit (DC-Biorad protein assay). Protein (500 µg) was used for the immunoprecipitation of NMDA
receptor protein and was incubated overnight at 4°C with 10 µg of
NR1 subunit antibody (Chemicon, Temecula, CA) in a total volume of 100 µl. Protein A sepharose (20 µl; Pharmacia, Uppsala, Sweden) was
added and incubated for 1 h at 4°C. The immunoprecipitates were
washed three times with lysis buffer and resuspended in 20 µl SDS
sample buffer (0.5 M Tris, pH 6.5, 20% glycerol, 4% SDS, 100 mM
dithiothreitol). Samples were equally divided in two. Proteins were
then separated by electrophoresis on two 4-12% gradient
Tris-glycine gels (Novex, San Diego, CA) and transferred to 0.2-mm
nitrocellulose membranes. Nonspecific binding was blocked by 1 h
incubation with 5% BSA or nonfat dry milk in Tris-buffered
saline-Tween 20. One of the membranes was incubated with an
antiphosphotyrosine antibody (PY20, 1:1,000; Upstate Biotechnology,
Lake Placid, NY) for 1 h. The second membrane was incubated overnight
at 4°C with either NMDA NR2A subunit antibody (1:500; Chemicon) or
NMDA NR2C antibody (1:500; Chemicon). Membranes were washed three times
with Tris-buffered saline-Tween 20 and incubated with secondary
antibodies for 1 h. After extensive washing, proteins were visualized
by enhanced chemiluminescence (Amersham), and semiquantitative analysis
of the bands was performed by scanning densitometry. It should be noted
that, because the immunoprecipitation was performed by using an
antibody against the NR1 subunit of the NMDA glutamate receptor, the
phosphotyrosine band at mol wt 180 may correspond to both the NR2A and
NR2B subunits, which migrate at identical molecular weights. In
addition, although the antibody against NR2A used in these experiments
is considered as specific (37), we cannot exclude with certainty that
some proportion of the phosphotyrosine bands or of the bands migrating
at mol wt 179-180 may in fact represent NR2B, which is tyrosine
phosphorylated. Therefore, results were normalized across experiments
by calculating the densitometry value ratios of antiphosphotyrosine to
NR2A/B for each sample.
Data analysis.
Values are reported as means ± SE unless otherwise indicated.
Changes in cardiovascular and ventilatory measurements were assessed
between the average of stable 3-min period recordings for epochs
preceding or following stimulus administration, such as microinjection
or hypoxia. The hypoxic response was considered as the highest
moving average of
E breath-by-breath
values measured over any given consecutive 3-min period during the
20-min hypoxic challenge. Differences among the various treatments
groups (baseline, treatment, and hypoxia) were compared by analysis of
variance (two-way ANOVA for repeated measures) followed by the
Newman-Keuls test for each drug. A P
value of <0.05 was set as statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Ventilatory responses.
Microinjection of the TK inhibitors Gen (10 mM) and A25 (1 mM) was not
associated with significant ventilatory changes
[P = not significant (NS) vs.
Veh]. Similarly, A1 administration did not elicit
E, f, or
VT changes (Figs.
1 and 2).
|
|
E increased from 118.4 ± 5.0 to 210.6 ± 13.2 ml/min (P < 0.001; Figs. 1 and 2). In contrast, after Gen treatment
(n = 13) significant attenuation of
HVR occurred (131.08 ± 9.1 to 176.2 ± 12.1 ml/min, Veh vs. Gen;
P < 0.01). The ventilatory reduction
by Gen during hypoxia was primarily due to f attenuations (P < 0.01) with no significant
differences in VT responses
(Fig. 2). Parallel attenuations of hypoxia-induced respiratory
alkalosis occurred, such that during hypoxia mean arterial blood pH was 7.563 ± 0.003 in Veh and 7.523 ± 0.005 in Gen
(P < 0.002).
Similar to Gen, HVR was significantly attenuated after A25 (1 mM)
microinjection in nine rats. Indeed, whereas
E increased from 137.3 ± 4.9 ml/min
in room air to 242.1 ± 20.0 ml/min in hypoxia after Veh
(P < 0.01; Fig. 2), after A25
treatment,
E increased from 148.5 ± 5.3 to 206.1 ± 10.9 ml/min (Veh vs. A25; P < 0.01). The reduction in HVR was
primarily mediated by attenuation of f with no changes in
VT responses (Fig. 2). Arterial
blood gases showed reduced increases in pH during hypoxia after A25 treatment (7.532 ± 0.007 after Veh vs. 7.496 ± 0.006 after A25; P < 0.002).
Administration of A1 (1 mM), the inactive analog to the TK inhibitor
A25, did not modify HVR in nine additional rats. After Veh
microinjection,
E increased from 128.9 ± 9.5 to 248.9 ± 21.0 ml/min
(P < 0.001; Fig. 2). Similarly,
after A1 administration,
E increased from
131.1 ± 7.9 to 239.1 ± 19.7 ml/min (Veh vs. A1;
P = NS). Arterial blood
gases showed no change in the increases in arterial pH during hypoxia
after A1 treatment (7. 520 ± 0.01 after Veh vs. 7.521 ± 0.01 after A1; P = NS).
Cardiovascular responses. Neither Gen (10 mM) nor A25 (1 mM) elicited significant alterations in MAP or HR during normoxia. Similarly, the chronotropic responses to hypoxia were unchanged after administration of TK inhibitors, such that HR increased by 8.6 ± 1.8, 7.5 ± 2.0, and 8.3 ± 2.1% in Veh, Gen, and A25, respectively (P = NS). No changes in MAP responses during hypoxia occurred in any of the treatment groups.
Tyrosine phosphorylation of NMDA receptor NR2 subunits.
Significant increases in tyrosine phosphorylation of the NR2A/B
subunits of the NMDA receptor (mol wt 179-180) occurred at 5, 30, and 60 min of hypoxia in the dorsocaudal brain stem and returned to
baseline values at 120 min (Fig. 3). No
changes in tyrosine phosphorylation of the NR2C subunit (mol wt 140)
occurred during the hypoxic challenge.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this study, inhibition of TK activity, within the neuronal structures of the dorsocaudal brain stem targeted by our microinjections, did not elicit significant changes in normoxic ventilation. Thus within these neural regions TK appears to play little if any respiratory role during normoxia. However, TK inhibitors significantly attenuated HVR, and such attenuation was primarily due to reduced f responses. The absence of any alterations in HR or MAP responses further suggests that TK are specifically involved in the hypoxic chemotransduction reflex within these regions.
The NTS within the dorsocaudal brain stem provides the first synaptic relay for primary afferent fibers originating from the peripheral chemo- and baroreceptors (11, 17). A substantial body of evidence supports a critical role for NMDA glutamate receptors within this brain stem region in mediating HVR (2, 19, 23, 28). Indeed, glutamate microinjections within this region will increase ventilatory output in conscious rats, whereas systemic or localized administration of NMDA receptor antagonists such as MK-801 will result in marked attenuation or abolition of HVR (24, 28). Such attenuation is clearly not due to removal of excitatory components, allowing for full expression of hypoxia-induced central inhibition, because parenteral administration of MK-801 was associated with significant reductions in the ventilatory response to selective peripheral chemoreceptor activation with sodium cyanide (28).
The NMDA receptor is composed of two major types of subunits: NR1 and NR2 subunits. Whereas NR1 subunits will form fully functional homooligomeric channels, NR2 subunits can only form heterodimeric receptors with NR1, which serve to modulate the channel properties of such receptors (4, 26, 27). The intracellular domain of NMDA glutamate receptors contains multiple consensus sites for serine-threonine and tyrosine phosphorylation, suggesting that various protein kinases, such as PKC and TK, may modulate receptor channel activity (6, 32, 34). Previous work from our laboratory indicates that, within the dorsocaudal brain stem, increases in PKC activity occur during hypoxia and that PKC inhibition elicits significant HVR attenuation in conscious rats (12-14). However, differences in the magnitude of HVR reduction between NMDA receptor and PKC antagonists further suggested that other signal transduction pathways may be functionally implicated in HVR. Arguments to support TKs as likely candidates for a modulatory role in HVR stem from several lines of work. 1) In dorsal horn and hippocampal neurons, NMDA receptor-mediated currents were regulated by protein tyrosine phosphorylation, whereas marked attenuation of such currents was demonstrated when protein TPs were activated (35, 36). 2) In the cerebral cortex, the NR2A and NR2B subunits of the NMDA receptor were shown to undergo tyrosine phosphorylation in vivo (21), and induction of long-term potentiation in the rat dentate gyrus parallels increases in tyrosine phosphorylation of the NMDA receptor 2B subunit (31). 3) In postsynaptic densities, the NR2B subunit is the major protein undergoing tyrosine phosphorylation (25). 4) Protein TKs of the src and fyn families control current fluxes through NMDA receptor channels (20). 5) Transient ischemia is associated with increased tyrosine phosphorylation of NMDA glutamate receptors (18, 33). 6) Finally, topical application of Gen to the dorsal surface of the medulla attenuates the phenylephrine-induced baroreflex in the rat (23). In this study, we now demonstrate that in vivo tyrosine phosphorylation of the NR2A/2B subunits, but not of the NR2C subunit, occurs during mild hypoxia within the dorsocaudal brain stem (Fig. 3).
The HVR attenuation in rats receiving dorsocaudal brain stem microinjections of either Gen or A25 further indicates that TK activation in the dorsocaudal brain stem during hypoxia may underlie important functional respiratory components of the HVR. In addition, increases in TK activity during hypoxia appear to modulate ventilatory frequency components and had no effect on VT. It should be stressed at this point that, although TK inhibitors affected the HVR, they did not modify any cardiovascular or ventilatory parameter during normoxia, suggesting that either the regions encompassed by the inhibitor or the TK basal activity in these neural sites do not appear to play a role in maintenance of eucapnic normoxic ventilation and cardiovascular regulatory mechanisms in the conscious rat. This is somewhat in contradistinction with Man et al. (23), who found that the chronotropic and baropressor responses to intravenous phenylephrine were mildly attenuated by topical application of Gen to the surface of the dorsocaudal brain stem of anesthetized rats. These discrepant results can be accommodated under the assumption that state (waking vs. anesthesia) may modify the dependency of the response to a stimulus, such that, when redundant drives are removed by the anesthesia, the functional role of TK in the modulation of the response to the challenge more fully emerges. Alternatively, and in clear agreement with our present findings, Gen application to the surface of the dorsocaudal brain stem did not modify the basal cardiovascular measurements of the anesthetized rats (23), further suggesting that TKs have little if any role in the tonic maintenance of HR or MAP.
Although we cannot definitively rule out the possibility that the TK inhibitors used in this study may have diffused to neighboring brain stem structures to elicit the alterations in HVR, it is noteworthy that, when the injection cannula were implanted within nondorsocaudal brain stem regions (data not shown), no significant effects on HVR occurred after administration of the TK inhibitors. Obviously the possibility exists that the diffusion of methylene blue and that each of the TK inhibitors employed herein may differ within the dorsocaudal brain stem. In such instances, the extent of such diffusion would not be precisely appreciated from extrapolations based on the methylene blue assessments. Thus it is possible that microinjections of TK inhibitors may have diffused more efficiently and, therefore, affected sites more remotely located than those suggested from the postmortem examination. Notwithstanding such unavoidable constraints in a freely behaving preparation, the gradient of drug concentrations created by the diffusion process would point to a higher concentration in the immediate vicinity of the cannula tip and, therefore, would suggest that most of the physiological alterations elicited by administration of TK inhibitors may be preferentially ascribed to neural regions encompassed within close proximity to the NTS. Of note, all animals studied demonstrated the predicted ventilatory and cardiovascular response to L-glutamate when it was microinjected in the NTS, further consolidating the implications of our findings.
The HVR effects are probably not related to the inherent properties of the particular TK inhibitor employed in these studies, because members of both common classes of TK inhibitors were used and elicited similar results. The first inhibitor used in this study, Gen, acts by binding to the ATP binding site (1). Although this inhibitor is widely used as a specific TK inhibitor, the possibility exists that Gen may have induced nonspecific inhibition of serine-threonine kinases (1). However, such a possibility is remote because A25, which inhibits TK activity by binding to the substrate-binding site of the enzyme (22), was associated with HVR attenuations of similar magnitude. In addition, the inactive analog to A25, A1, had no effect on the ventilatory response to either normoxia or hypoxia. Therefore, the results obtained in this study indicate that the HVR attenuation induced by the two TK inhibitors is indeed due to TK inhibition and most probably does not represent modulation of other kinases such as PKC or protein kinase A.
The physiological role(s) of the various TKs within neurons underlying cardiorespiratory functions has yet to be established. The present study merely indicates that hypoxia induces temporally constrained changes in tyrosine phosphorylation of particular NMDA glutamate receptor subunits and that the HVR is modified by application of TK inhibitors to the dorsocaudal brain stem. From presently available evidence, TKs and TPs are thought to act together and thus create a delicate balance controlling neuronal activity, such that in isolated neurons for example, NMDA currents are potentiated by TK and attenuated by TP (35). Thus in the context of HVR constituting a predominantly glutamatergic response, the early activation of functionally relevant TK within respiratory neurons could potentiate the early HVR. In contrast, subsequent activation of TP could allow for more precise modulation of neuronal discharge and thereby permit onset of hypoxic ventilatory roll-off. Furthermore, in analogy to the hippocampal slice preparation, in which anoxic stimulation leads to a selective inhibition of protein TK activity leading to tyrosine-dephosphorylation of the NMDA receptor (5), accentuation of the severity of hypoxemia would be expected to induce rapid deactivation of the functionally relevant TK and lead to apnea. Thus improved understanding of the various signal transduction elements mediating the intracellular response magnitude and temporal domains may allow for development of better pharmacological interventions during disease states associated with hypoxia.
In summary, administration of TK inhibitors within the dorsocaudal brain stem attenuates frequency components and the magnitude of the ventilatory response to hypoxia in conscious rats, whereas it has no apparent effect on cardiovascular responses. Furthermore, we have shown that tyrosine phosphorylation of the NR2A/NR2B subunits of NMDA receptors, a critical voltage-gated receptor in HVR within the dorsocaudal brain stem, occurs during acute hypoxic challenges. We postulate that protein tyrosine phosphorylation events within neuronal populations of the dorsocaudal brain stem mediate functionally important signal transduction pathways of HVR.
| |
ACKNOWLEDGEMENTS |
|---|
This study was supported in part by National Institute of Child Health and Human Development Grant HD-01072, Maternal and Child Health Bureau Grant MCJ-229163, and American Lung Association Grant CI-002-N (to D. Gozal). M. A. Czapla was supported by a predoctoral fellowship from the Louisiana Chapter of the American Heart Association and is presently a recipient of a National Institutes of Health National Research Service Award Predoctoral Fellowship (1F31DA05948-01).
| |
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: D. Gozal, Section of Pediatric Pulmonology, Dept. of Pediatrics, SL-37, Tulane Univ. School of Medicine, 1430 Tulane Ave., New Orleans, LA 70112 (E-mail: dgozal{at}tmcpop.tmc.tulane.edu).
Received 3 November 1998; accepted in final form 10 March 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Akiyama, T.,
and
H. Ogawara.
Use and specificity of genistein as inhibitor of protein-tyrosine kinase.
In: Protein Phosphorylation, edited by B. M. Sefton,
and T. Hunter. San Diego, CA: Academic, 1991, vol. 201, p. 362-371.
2.
Ang, R. C.,
B. Hoop,
and
H. Kazemi.
Role of glutamate as the central neurotransmitter in the hypoxic ventilatory response.
J. Appl. Physiol.
72:
1480-1487,
1992
3.
Bartlett, D. J. B.,
and
S. W. Tenney.
Control of breathing in experimental anemia.
Respir. Physiol.
10:
384-395,
1970[Medline].
4.
Blahos, J. I.,
and
R. J. Wenthold.
Relationship between N-methyl-D-aspartate receptor NR1 splice variants and NR2 subunits.
J. Biol. Chem.
271:
15669-15674,
1996
5.
Braunton, J. L.,
V. Wong,
W. Wang,
M. W. Salter,
J. Roder,
M. Liu,
and
Y. T. Wang.
Reduction of tyrosine kinase activity and protein tyrosine dephosphorylation by anoxic stimulation in vitro.
Neuroscience
82:
161-170,
1998[Medline].
6.
Chen, L.,
and
L. Y. M. Huang.
Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation.
Nature
356:
521-523,
1992[Medline].
7.
Chen, S.,
and
J. P. Leonard.
Protein tyrosine kinase-mediated potentiation of currents from cloned NMDA receptors.
J. Neurochem.
67:
194-200,
1996[Medline].
8.
Drorbaugh, J. E.,
and
W. O. Fenn.
A barometric method for measuring ventilation in newborn infants.
Pediatrics
16:
81-87,
1955
9.
Durand, G. M.,
M. V. L. Bennett,
and
R. S. Zukin.
Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C.
Proc. Natl. Acad. Sci. USA
90:
6731-6735,
1993
10.
Epstein, R. A.,
M. A. F. Epstein,
G. G. Haddad,
and
R. B. Mellins.
Practical implementation of the barometric method for measurement of tidal volume.
J. Appl. Physiol.
49:
1107-1115,
1980
11.
Finley, J. C. W.,
and
D. M. Katz.
The central organization of carotid body afferent projections to the brain stem of the rat.
Brain Res.
572:
108-116,
1992[Medline].
12.
Gozal, D.,
and
E. Gozal.
Hypoxic ventilatory roll-off is associated with decreases in protein kinase C activation within the nucleus tractus solitarius of the rat.
Brain Res.
774:
246-249,
1997[Medline].
13.
Gozal, D.,
G. R. Graff,
J. Torres,
S. Khicha,
G. Nayak,
N. Simakajornboon,
and
E. Gozal.
Cardiorespiratory responses to systemic administration of a protein kinase C inhibitor in the conscious rat.
J. Appl. Physiol.
84:
641-648,
1998
14.
Gozal, E.,
A. Roussel,
G. Holt,
L. Gozal,
Y. Gozal,
J. Torres,
and
D. Gozal.
Protein kinase C modulation of the ventilatory response to hypoxia in the nucleus tractus solitarius of the conscious rat.
J. Appl. Physiol.
84:
1982-1990,
1998
15.
Haibara, A. S.,
L. G. H. Bonagamba,
and
B. H. Machado.
Sympathoexcitatory neurotransmission of the chemoreflex in the NTS of awake rats.
Am. J. Physiol.
276 (Regulatory Integrative Comp. Physiol. 45):
R69-R80,
1999
16.
Hollman, M.,
C. Maron,
and
S. Heinemann.
Cloned glutamate receptors.
Annu. Rev. Neurosci.
17:
31-108,
1994[Medline].
17.
Housley, G. D.,
and
J. D. Sinclair.
Localization of kainic acid lesions of neurons transmitting the carotid chemoreceptor stimulus for respiration in the rat.
J. Physiol. (Lond.)
406:
99-114,
1988
18.
Hu, B.,
and
T. Wieloch.
Tyrosine phosphorylation and activation of mitogen-activated protein kinases in the rat brain following transient cerebral ischemia.
J. Neurochem.
62:
1357-1367,
1994[Medline].
19.
Kazemi, H.,
and
B. Hoop.
Glutamic acid and
-butyric acid neurotransmitters in central control of breathing.
J. Appl. Physiol.
70:
1-7,
1991
20.
Kohr, G.,
and
P. Seeburg.
Subtype-specific regulation of recombinant NMDA receptor-channels by protein tyrosine kinases of the src family.
J. Physiol. (Lond.)
492:
445-452,
1996[Medline].
21.
Lau, L.,
and
R. Huganir.
Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits.
J. Biol. Chem.
270:
20036-20041,
1995
22.
Levitzki, A.,
A. Gazit,
N. Osherov,
I. Posner,
and
G. Chiam.
Inhibition of protein-tyrosine kinases by tyrphostins.
In: Protein Phosphorylation, edited by B. M. Sefton,
and T. Hunter. San Diego, CA: Academic, 1991, vol. 201, p. 346-361.
23.
Man, H.-Y.,
T. Erclik,
L. E. Becker,
and
Y. T. Wang.
Modulation of baroreflex sensitivity by the state of protein tyrosine phosphorylation in the brain stem of the rat.
Brain Res.
792:
141-148,
1998[Medline].
24.
Mizusawa, A.,
H. Ogawa,
Y. Kikuchi,
W. Hida,
H. Kurosawa,
S. Okabe,
T. Takishima,
and
K. Shirato.
In vivo release of glutamate in nucleus tractus solitarii of the rat during hypoxia.
J. Physiol. (Lond.)
478:
55-65,
1994[Medline].
25.
Moon, I. S.,
M. L. Apperson,
and
M. B. Kennedy.
The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit B.
Proc. Natl. Acad. Sci. USA
91:
3954-3958,
1994
26.
Moriyoshi, K.,
M. Masu,
T. Ishii,
R. Shigemoto,
N. Mizuno,
and
S. Nakanishi.
Molecular cloning and characterization of the rat NMDA receptor.
Nature
354:
31-37,
1991[Medline].
27.
Nakanishi, S.
Molecular diversity of glutamate receptors and implications for brain function.
Science
258:
597-603,
1992
28.
Ohtake, P. J.,
J. E. Torres,
Y. M. Gozal,
G. R. Graff,
and
D. Gozal.
NMDA receptors mediate peripheral chemoreceptor afferent input in the conscious rat.
J. Appl. Physiol.
83:
853-861,
1998.
29.
Pappenheimer, J.
Sleep and respiration of rats during hypoxia.
J. Physiol. (Lond.)
266:
191-207,
1977
30.
Paxinos, G.,
and
C. Watson.
The Rat Brain in Stereotaxic Coordinates. New York: Academic, 1986.
31.
Rosenblum, K.,
Y. Dudai,
and
G. Richter-Levin.
Long-term potentiation increases tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit 2B in vivo.
Proc. Natl. Acad. Sci. USA
93:
10457-10460,
1996
32.
Swartz, K.,
A. Merritt,
B. Bean,
and
D. Lovinger.
Protein kinase C modulates glutamate receptor inhibition of Ca2+ channels and synaptic transmission.
Nature
361:
165-168,
1993[Medline].
33.
Takagi, N.,
K. Shinno,
L. Teves,
N. Bissoon,
M. Wallace,
and
J. Gurd.
Transient ischemia differentially increases tyrosine phosphorylation of NMDA receptor subunits 2A and 2B.
J. Neurochem.
69:
1060-1065,
1997[Medline].
34.
Tingley, W.,
K. Roche,
A. Thompson,
and
R. Huganir.
Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain.
Nature
364:
70-73,
1993[Medline].
35.
Wang, Y. T.,
and
M. W. Salter.
Regulation of NMDA receptors by tyrosine kinases and phosphatases.
Nature
369:
233-235,
1994[Medline].
36.
Wang, Y. T.,
X. M. Yu,
and
M. W. Salter.
Ca2+-independent reduction of N-methyl-D-aspartate channel activity by protein tyrosine phosphatase.
Proc. Natl. Acad. Sci. USA
93:
1721-1725,
1996
37.
Wenthold, R. J.,
N. Yokotani,
K. Doi,
and
K. Wada.
Immunochemical characterization of the non-NMDA glutamate receptor using subunit-specific antibodies: evidence for a hetero-oligomeric structure in rat brain.
J. Biol. Chem.
267:
501-507,
1992
This article has been cited by other articles:
![]() |
P. M. de Paula, G. Tolstykh, and S. Mifflin Chronic intermittent hypoxia alters NMDA and AMPA-evoked currents in NTS neurons receiving carotid body chemoreceptor inputs Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2259 - R2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Reid and F. L. Powell Effects of chronic hypoxia on MK-801-induced changes in the acute hypoxic ventilatory response J Appl Physiol, December 1, 2005; 99(6): 2108 - 2114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Reeves, E. S. Carter, S. Z. Guo, and D. Gozal Calcium/calmodulin-dependent kinase II mediates critical components of the hypoxic ventilatory response within the nucleus of the solitary tract in adult rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R871 - R876. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. GOZAL and C. GAULTIER Evolving Concepts of the Maturation of Central Pathways Underlying the Hypoxic Ventilatory Response Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 325 - 329. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |